The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

Overview of attention for article published in BMC Infectious Diseases, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

policy: 1 policy source

twitter: 17 X users

Readers on

mendeley: 102 Mendeley

Summary Policy documents X

So far, Altmetric has seen 3 policy documents that reference this research output.

Lignes directrices unifiées de l’OMS sur la tuberculose : module 4 : traitement : traitement de la tuberculose pharmacorésistante

Cited by World Health Organization on 04 Oct 2023

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment

Cited by World Health Organization on 15 Dec 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Prevention and management of hearing loss in patients receiving ototoxic medications

Cited by World Health Organization on 04 Dec 2022

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.